JOHNSON & JOHNSON
10-Q, EX-27, 2000-08-15
PHARMACEUTICAL PREPARATIONS
Previous: JOHNSON & JOHNSON, 10-Q, 2000-08-15
Next: IMCO RECYCLING INC, NT 10-Q, 2000-08-15



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUL-02-2000
<CASH>                                           2,937
<SECURITIES>                                     1,562
<RECEIVABLES>                                    4,799
<ALLOWANCES>                                       358
<INVENTORY>                                      3,060
<CURRENT-ASSETS>                                14,366
<PP&E>                                          11,263
<DEPRECIATION>                                   4,571
<TOTAL-ASSETS>                                  30,305
<CURRENT-LIABILITIES>                            6,605
<BONDS>                                          2,456
                                0
                                          0
<COMMON>                                         1,535
<OTHER-SE>                                      16,444
<TOTAL-LIABILITY-AND-EQUITY>                    30,305
<SALES>                                         14,827
<TOTAL-REVENUES>                                14,827
<CGS>                                            4,497
<TOTAL-COSTS>                                    4,497
<OTHER-EXPENSES>                                 1,304
<LOSS-PROVISION>                                    20
<INTEREST-EXPENSE>                                  84
<INCOME-PRETAX>                                  3,758
<INCOME-TAX>                                     1,113
<INCOME-CONTINUING>                              2,645
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,645
<EPS-BASIC>                                     1.90
<EPS-DILUTED>                                     1.87


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission